Can Colchicine Kill You? How Overdose Causes Toxicity

Colchicine can absolutely kill, and it does not take much. The drug has one of the narrowest gaps between a helpful dose and a fatal one in all of medicine, with toxic effects showing up at blood concentrations only slightly above those needed for treatment. Most people encounter colchicine as a small pill prescribed for gout flares or pericarditis, so the idea that the same tablet could be lethal catches them off guard. But the pharmacology is unforgiving, and understanding how toxicity unfolds matters for anyone who keeps this drug in their medicine cabinet.

Why the Gap Between Medicine and Poison Is So Thin

Colchicine’s danger comes down to its narrow therapeutic index. Effective steady-state blood levels have been reported in the range of roughly 0.5 to 3 micrograms per liter, and toxic effects begin to appear at around that same 3 microgram-per-liter mark.¹ In practical terms, the dose that relieves your gout attack and the dose that starts poisoning you are uncomfortably close together. The separation between therapeutic and toxic doses is, as regulators have put it, “not well defined.”²

Making matters worse, colchicine’s pharmacokinetics seem designed to maximize the danger. After you swallow a tablet, it reaches peak blood levels within about an hour, but it then spreads into a massive volume of body tissue, with distribution volumes reported between roughly 400 and 700 liters, far exceeding your actual body volume.³ That means colchicine buries itself deep in your tissues, particularly in organs with rapidly dividing cells. Once it is there, it stays: the terminal half-life runs anywhere from about 20 hours to nearly 60 hours depending on the study and the individual.⁴ This long residence time means you cannot simply pump someone’s stomach and expect the problem to go away. By the time symptoms appear, much of the drug has already left the bloodstream and lodged in cells.

How Colchicine Damages Cells

Colchicine works by binding to tubulin, a structural protein that cells use to build microtubules. Microtubules are the internal scaffolding that cells depend on for division, intracellular transport, and maintaining their shape. Colchicine latches onto soluble tubulin and forms complexes that cap the growing ends of microtubules, preventing them from extending.⁵ At low concentrations, it simply slows microtubule growth. At higher concentrations, it actively promotes microtubule breakdown.⁶

At therapeutic doses, this disruption mainly affects white blood cells, which is why colchicine works as an anti-inflammatory. But in overdose, the same mechanism becomes indiscriminate. Every cell that needs to divide or move things around internally gets hit. The gut lining, bone marrow, heart muscle, liver, kidneys: all of these rely on functional microtubules, and all of them can be damaged when colchicine concentrations climb too high. The binding is also described as “poorly reversible,” meaning once colchicine attaches to tubulin, the complex does not readily let go.⁵ This irreversibility is one reason colchicine poisoning is so difficult to reverse once it has started.

The Three Phases of Colchicine Poisoning

Colchicine toxicity does not arrive all at once. It unfolds in three recognized phases, each more dangerous than the last, and the progression can feel deceptively manageable in the early hours.

The first phase typically hits within 10 to 24 hours of ingestion and looks like a bad stomach bug: severe abdominal pain, vomiting, diarrhea, and sometimes gastrointestinal bleeding.⁷ Because these symptoms mimic food poisoning or gastroenteritis, the true cause can be missed entirely if no one knows about the colchicine exposure. One case report described a patient presenting with severe abdominal pain as the initial sign of what turned out to be colchicine overdose complicated by rhabdomyolysis and plummeting white blood cell counts.⁸

The second phase, from roughly 24 hours to seven days after ingestion, is where people die. This is the multi-organ dysfunction stage. Bone marrow suppression causes white blood cell counts to crash, leaving the body defenseless against infection. The heart can develop arrhythmias or outright cardiovascular collapse. Kidneys and liver start failing. Rhabdomyolysis, the breakdown of muscle tissue, floods the bloodstream with proteins that further damage the kidneys. Death in this phase typically results from rapidly progressive multi-organ failure compounded by sepsis.⁹ One documented case involved a woman who developed multiple organ failure and severe bone marrow suppression after ingesting 50 milligrams of colchicine.¹⁰

The third phase is only seen in people who survive. Starting after about day seven, organ function begins to recover, white blood cell counts rebound (sometimes overshooting into a temporary spike), and alopecia, or hair loss, becomes visible as the drug’s earlier assault on rapidly dividing hair follicle cells catches up.¹¹ Recovery is generally complete in people who make it through the second phase, though complications from the acute illness can linger.

How Much Colchicine Is Lethal

The commonly cited lethal threshold is around 0.8 milligrams per kilogram of body weight.¹² For an average adult weighing around 70 kilograms, that works out to roughly 56 milligrams, which could be as few as 56 standard one-milligram tablets or 112 of the more common half-milligram tablets. That sounds like a lot of pills until you consider that someone prescribed colchicine for familial Mediterranean fever might have hundreds of tablets at home.

But the 0.8 mg/kg figure is not a safe threshold below which nothing bad happens. A ten-year review of pediatric poisoning cases in the UK recorded deaths at estimated ingested doses as low as 0.21 mg/kg, though all of the fatalities in that series involved mixed overdoses with other substances.¹³ In another series of 23 children, doses between 0.5 and 0.8 mg/kg were classified as “toxic” rather than lethal, yet three children in the overall cohort died.¹⁴ So the lethal dose varies significantly depending on the person’s size, age, organ function, and what other substances they have on board. Treating any large intentional ingestion as potentially fatal is the clinical reality.

Drug Interactions That Turn Safe Doses Dangerous

One of the most treacherous aspects of colchicine toxicity is that you do not always need an overdose to be poisoned. Certain medications dramatically slow the body’s ability to clear colchicine, effectively turning a normal prescription dose into a toxic one. The main culprits are drugs that inhibit two pathways the body uses to metabolize and transport colchicine: the enzyme CYP3A4 and a transporter called P-glycoprotein.

The most concerning interactions involve macrolide antibiotics like clarithromycin and erythromycin. A cohort study found that combining colchicine with any macrolide antibiotic was associated with roughly an eightfold higher risk of rhabdomyolysis based on laboratory values, and the risk climbed even higher when the macrolide was a strong CYP3A4 inhibitor like clarithromycin.¹⁵ An analysis of the FDA’s adverse event reporting system found hundreds of reports involving colchicine combined with drugs that inhibit both CYP3A4 and P-glycoprotein. Among those reports where severity was noted, about a quarter mentioned death.¹⁶

Other drugs in this category include certain antifungals, HIV protease inhibitors, and calcium channel blockers like verapamil and diltiazem. If you take colchicine regularly and get prescribed any new medication, the interaction risk is worth flagging with your pharmacist. The fact that colchicine itself is old, inexpensive, and rarely thought of as “serious” medicine makes these interactions easy to overlook.

Who Is Most Vulnerable

Beyond drug interactions, several patient-specific factors raise the risk of colchicine toxicity at ordinary doses. Kidney and liver impairment top the list, since colchicine depends on both organs for clearance. Older adults are at higher risk partly because kidney function naturally declines with age and partly because they are more likely to be on interacting medications.² Anyone with existing liver or kidney disease should be on a reduced dose or monitored more carefully, though the evidence suggests this adjustment does not always happen in practice.

Children represent a special concern. A UK series spanning a decade found 57 pediatric colchicine poisoning cases, with about one in five progressing to systemic toxicity and four deaths.¹³ Children who accidentally swallow even a few of a parent’s tablets may reach toxic thresholds quickly because the per-kilogram dose is so much higher in a small body. In reported pediatric cases, the clinical picture ranged from nothing at all (in one child who ingested a low dose) to gastroenteritis, fever, liver dysfunction, and hair loss in others who needed supportive care over days.¹⁷ The variability is part of what makes colchicine so difficult to manage: the same milligram dose can be trivial for one person and devastating for another.

Accidental Poisoning From Plants

Not all colchicine poisoning comes from pills. Colchicine occurs naturally in the autumn crocus (Colchicum autumnale), a plant whose leaves can be mistaken for wild garlic or ramsons in the spring when neither plant is flowering. One reported case described a 43-year-old woman who developed severe multi-organ injury after eating autumn crocus that she believed was wild garlic; both plants grow in similar damp meadow habitats and look similar before blossoms appear.¹⁸ A decade of French toxicovigilance data confirmed that autumn crocus is one of the leading causes of moderate-to-severe accidental plant poisoning in adults, alongside water dropwort and foxglove.¹⁹

Plant-based poisoning is particularly dangerous because the amount of colchicine in a serving of misidentified leaves is unpredictable. There is no standardized “dose” the way there would be with pharmaceutical tablets, and foragers often do not think to mention what they ate when they show up at the emergency department with gastrointestinal symptoms. If you forage for wild garlic in Europe, the simplest safety check is to crush a leaf and smell it: garlic leaves smell strongly of garlic, while autumn crocus leaves have no smell.

Why Colchicine Poisoning Is Hard to Diagnose

One of the most frustrating aspects of colchicine toxicity, from a medical standpoint, is that it is difficult to confirm quickly. Serum colchicine level testing is not routinely available in most hospitals.²⁰ Even after a massive overdose, colchicine may be undetectable in blood because the drug distributes so rapidly and extensively into tissues. Forensic investigations have found that bile is a much better sample for detecting colchicine than blood, because the drug undergoes extensive enterohepatic recirculation before being excreted.²¹

The practical consequence is that clinicians must rely on the clinical picture, a patient or family member reporting the ingestion, and lab trends over time rather than a single confirmatory blood test. This delay matters because early intervention is the only real tool available once colchicine has been absorbed.

Treatment and the Search for an Antidote

There is currently no approved antidote for colchicine poisoning in humans. Treatment is entirely supportive: intravenous fluids, electrolyte management, vasopressors for cardiovascular collapse, ventilator support if needed, and granulocyte colony-stimulating factor to try to boost white blood cell production after marrow suppression kicks in. A recent case report described a patient who recovered fully after a combination of early plasma exchange, non-invasive ventilation, and colony-stimulating factor therapy, but the authors framed it as a multimodal approach rather than any single intervention being decisive.²²

The most promising antidote research involves anti-colchicine antibody fragments, or Fab fragments, which work on the same principle as the antivenom used for digoxin poisoning. In animal studies, these fragments have shown remarkable results. In one pig model, a full neutralizing dose of anti-colchicine Fab given within hours of poisoning pulled colchicine out of tissues and into the bloodstream, increasing urinary elimination roughly twofold and preventing the cardiovascular collapse that killed untreated animals. All four treated pigs survived to 48 hours with no significant heart damage.²³ Earlier mouse studies showed survival rates of 70 to 80 percent in animals given a dose of colchicine that was otherwise 100 percent fatal, even when the Fab fragments were administered 90 minutes after poisoning.²⁴ A follow-up study showed that even delayed treatment at six hours still rescued half of poisoned mice, and that effectiveness scaled linearly with dose.²⁵

Despite these encouraging animal results, anti-colchicine Fab fragments have not yet made it through human clinical trials. The gap between animal proof-of-concept and a product in hospital pharmacies remains wide. For now, the best defense against colchicine toxicity is prevention: careful dosing, awareness of drug interactions, keeping tablets out of reach of children, and never exceeding prescribed amounts even when a gout flare feels unbearable.

How Colchicine Compares to Other Microtubule-Targeting Agents

Colchicine is not the only compound that disrupts microtubules. Vinca alkaloids like vincristine and vinblastine, used in cancer chemotherapy, work through a related mechanism. But the pattern of damage differs. An experimental comparison of several microtubule-disrupting compounds found that colchicine was selectively toxic to certain brain cells, while vincristine was broadly toxic and less selective. The ordering of toxicity across these compounds correlated with how irreversibly each one binds to tubulin.²⁶ Lumicolchicine, a breakdown product of colchicine created by exposing it to light, caused no more damage than a plain injection, which is one reason researchers have historically used it as a control substance in experiments.

The clinical takeaway is that colchicine’s particular pattern of binding, tight and poorly reversible, is exactly what makes it both medically useful in tiny doses and catastrophically dangerous in larger ones. Drugs that bind tubulin loosely tend to be less potent therapeutically and less toxic. Colchicine sits at the unfortunate intersection of high potency and high risk, which is why it has been described as one of the oldest drugs in medicine and one that continues to demand healthy respect from anyone who prescribes or takes it.²⁷